Search results
3 hours ago · Novavax has filed with the U.S. FDA and EMA, and is working with other regulatory authorities globally on authorization or approval of its updated COVID-19 vaccine. About the Novavax COVID-19 2024-2025 Formula (NVX-CoV2705) NVX-CoV2705 is an updated version of Novavax's prototype COVID-19 vaccine (NVX-CoV2373) formulated to target the JN.1 ...
15 hours ago · Novavax's COVID-19 vaccine would be the only protein-based option available in Canada, if authorizedNovavax's filing is aligned with NACI, U.S. FDA, EMA and WHO recommendations on vaccine...
